Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 27, 2014

A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis

  • Ahmet Anık , Gönül Çatlı , Ayhan Abacı , Uluc Yiş , Hale Ören , Handan Güleryüz , Sefa Kızıldağ and Ece Böber EMAIL logo

Abstract

Neonatal diabetes mellitus is a rare clinical condition, which develops most commonly secondary to mutations in KCNJ11 and ABCC8 genes encoding ATP-sensitive K+ channels. Patients are typically diagnosed with hyperglycemia-related symptoms in the first 6 months of life and rarely with ketoacidosis. In this article, we report an infant who presented with focal clonic convulsion and thereafter was diagnosed with neonatal diabetes mellitus and thrombi in cerebral venous sinus. In this patient, after a molecular analysis of the ABCC8 gene revealed a novel heterozygous missense mutation (p.D424V), a successful transition from insulin to sulfonylurea treatment was made.


Corresponding author: Ece Böber, MD, Professor, Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Dokuz Eylül University, Balçova-Izmir, 35340 Turkey, Phone: +90 232 4126076, Fax: +90 232 4126001, E-mail:

Acknowledgments

Genetic testing was provided by the Molecular Genetics Laboratory at the University of Exeter Medical School with funding from the Wellcome Trust to Professors Andrew Hattersley and Sian Ellard (http://www.diabetesgenes.org).

References

1. Slingerland AS, Shields BM, Flanagan SE, Bruining GJ, Noordam K, et al. Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 2009;52:1683–5.10.1007/s00125-009-1416-6Search in Google Scholar PubMed PubMed Central

2. Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson LH. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab 2010;21:464–72.10.1016/j.tem.2010.03.004Search in Google Scholar PubMed PubMed Central

3. Abacı A, Razi CH, Ozdemir O, Hızlı S, Kıslal F, et al. Neonatal diabetes mellitus accompanied by diabetic ketoacidosis and mimicking neonatal sepsis: a case report. J Clin Res Pediatr Endocrinol 2010;2:131–3.10.4274/jcrpe.v2i3.131Search in Google Scholar PubMed PubMed Central

4. Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis 2007;2:12.10.1186/1750-1172-2-12Search in Google Scholar PubMed PubMed Central

5. Vazzana N, Ranalli P, Cuccurullo C, Davi G. Diabetes mellitus and thrombosis. Thromb Res 2012;129:371–7.10.1016/j.thromres.2011.11.052Search in Google Scholar PubMed

6. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990;13:22–33.10.2337/diacare.13.1.22Search in Google Scholar PubMed

7. Funk SD, Yurdagul A Jr., Orr AW. Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med 2012;2012:569654.10.1155/2012/569654Search in Google Scholar PubMed PubMed Central

8. Nordt TK, Bode C. Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approaches. Semin Thromb Hemost 2000;26:495–501.10.1055/s-2000-13205Search in Google Scholar PubMed

9. Romano M, Pomilio M, Vigneri S, Falco A, Chiesa PL, et al. Endothelial perturbation in children and adolescents with type 1 diabetes: association with markers of the inflammatory reaction. Diabetes Care 2001;24:1674–8.10.2337/diacare.24.9.1674Search in Google Scholar PubMed

10. Giusti C, Schiaffini R, Brufani C, Pantaleo A, Vingolo EM, et al. Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients. Br J Ophthalmol 2000;84:591–5.10.1136/bjo.84.6.591Search in Google Scholar PubMed PubMed Central

11. Reverter JL, Reverter JC, Tassies D, Rius F, Monteagudo J, et al. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus. Am J Hematol 1997;56:93–9.10.1002/(SICI)1096-8652(199710)56:2<93::AID-AJH4>3.0.CO;2-WSearch in Google Scholar

12. Rodrigues TC, Snell-Bergeon JK, Maahs DM, Kinney GL, Rewers M. Higher fibrinogen levels predict progression of coronary artery calcification in adults with type 1 diabetes. Atherosclerosis 2010;210:671–3.10.1016/j.atherosclerosis.2009.12.034Search in Google Scholar

13. Santilli F, Basili S, Ferroni P, Davi G. CD40/CD40L system and vascular disease. Intern Emerg Med 2007;2:256–68.10.1007/s11739-007-0076-0Search in Google Scholar

14. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, et al. Hyperglycemia: a prothrombotic factor? J Thromb Haemost 2010;8:1663–9.10.1111/j.1538-7836.2010.03910.xSearch in Google Scholar

15. Yang JY, Chan AK, Callen DJ, Paes BA. Neonatal cerebral sinovenous thrombosis: sifting the evidence for a diagnostic plan and treatment strategy. Pediatrics 2010;126:e693–700.10.1542/peds.2010-1035Search in Google Scholar

16. deVeber G, Monagle P, Chan A, MacGregor D, Curtis R, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539–43.10.1001/archneur.55.12.1539Search in Google Scholar

17. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417–23.10.1056/NEJM200108093450604Search in Google Scholar

18. Heller C, Heinecke A, Junker R, Knofler R, Kosch A, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003;108:1362–7.10.1161/01.CIR.0000087598.05977.45Search in Google Scholar

19. Monagle P, Chalmers E, Chan A, deVeber G, Kirkham F, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133:887S–968S.10.1378/chest.08-0762Search in Google Scholar

20. Edghill EL, Flanagan SE, Ellard S. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11. Rev Endocr Metab Disord 2010;11:193–8.10.1007/s11154-010-9149-xSearch in Google Scholar

21. Rubio-Cabezas O, Klupa T, Malecki MT. Permanent neonatal diabetes mellitus – the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest 2011;41:323–33.10.1111/j.1365-2362.2010.02409.xSearch in Google Scholar PubMed

22. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204–9.10.2337/dc07-1785Search in Google Scholar PubMed PubMed Central

Received: 2013-6-28
Accepted: 2013-11-22
Published Online: 2014-1-27
Published in Print: 2014-5-1

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 5.6.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2013-0263/html
Scroll to top button